ATE240311T1 - Verfahren zur herstellung von 2-thienylamin- derivaten - Google Patents

Verfahren zur herstellung von 2-thienylamin- derivaten

Info

Publication number
ATE240311T1
ATE240311T1 AT98913841T AT98913841T ATE240311T1 AT E240311 T1 ATE240311 T1 AT E240311T1 AT 98913841 T AT98913841 T AT 98913841T AT 98913841 T AT98913841 T AT 98913841T AT E240311 T1 ATE240311 T1 AT E240311T1
Authority
AT
Austria
Prior art keywords
pct
general formula
alkali metal
metal atom
date sep
Prior art date
Application number
AT98913841T
Other languages
English (en)
Inventor
Bertrand Castro
Jean-Robert Dormoy
Aldo Previero
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of ATE240311T1 publication Critical patent/ATE240311T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT98913841T 1997-03-05 1998-03-05 Verfahren zur herstellung von 2-thienylamin- derivaten ATE240311T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9702621A FR2760456B1 (fr) 1997-03-05 1997-03-05 Procede de preparation de derives de 2-thienyl-ethylamine
PCT/FR1998/000441 WO1998039322A1 (fr) 1997-03-05 1998-03-05 Procede de preparation de derives de 2-thienylethylamine

Publications (1)

Publication Number Publication Date
ATE240311T1 true ATE240311T1 (de) 2003-05-15

Family

ID=9504438

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98913841T ATE240311T1 (de) 1997-03-05 1998-03-05 Verfahren zur herstellung von 2-thienylamin- derivaten

Country Status (12)

Country Link
US (1) US6080875A (de)
EP (1) EP0971915B1 (de)
JP (1) JP4283896B2 (de)
AT (1) ATE240311T1 (de)
AU (1) AU6839498A (de)
BR (1) BR9808174B1 (de)
CA (1) CA2283126C (de)
DE (1) DE69814608T2 (de)
ES (1) ES2200332T3 (de)
FR (1) FR2760456B1 (de)
NO (1) NO323613B1 (de)
WO (1) WO1998039322A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6800759B2 (en) 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
WO2004081015A1 (en) * 2003-03-10 2004-09-23 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
WO2004081016A1 (en) 2003-03-12 2004-09-23 Cadila Healthcare Limited Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate
PT1680430E (pt) 2003-11-03 2010-04-26 Cadila Healthcare Ltd Processos para a preparação da forma i de bissulfato de (s)-(+)-clopidogrel
WO2006003671A1 (en) * 2004-07-02 2006-01-12 Srinivasa Reddy Battula A process for resolution of methylamino(2-chlorophenyl)acetate
EP1704152A2 (de) * 2004-09-21 2006-09-27 Teva Pharmaceutical Industries Ltd Kristallines clopidogrelhydrobromid und verfahren zu dessen herstellung
CA2594763A1 (en) * 2005-02-24 2006-08-31 Teva Pharmaceutical Industries Ltd. Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
US20090247569A1 (en) * 2006-08-03 2009-10-01 Claude Singer Process for Preparing Clopidogrel Bisulphate
EP1980563A1 (de) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Verfahren zur Herstellung von Methyl (+)-(S)-Alpha-(O-Chlorophenyl)-6,7-Dihydrothieno-[3,2-C]pyridine-5(4H) Acetat
MX2008016012A (es) * 2007-04-18 2009-03-06 Teva Pharma Proceso mejorado para preparar clopidogrel.
EP2107061A1 (de) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Herstellungsverfahren für optisch angereichertes Clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
KR100990949B1 (ko) 2008-06-09 2010-10-29 엔자이텍 주식회사 클로피도그렐 및 그의 유도체의 제조방법
WO2010046476A1 (en) * 2008-10-24 2010-04-29 Sandoz Ag A process for the preparation of s-clopidogrel
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
WO2012123958A1 (en) 2011-02-14 2012-09-20 Cadila Healthcare Limited Highly pure salts of clopidogrel free of genotoxic impurities
CN103172527A (zh) * 2011-12-26 2013-06-26 湖北德洲科技发展有限公司 一种制备氯吡格雷合成中间体-邻氯苯甘氨酸甲酯的方法
RS56178B1 (sr) * 2012-07-17 2017-11-30 Sanofi Sa Upotreba vegfr-3 inhibitora za lečenje hepatocelularnog karcinoma
CN106748853B (zh) * 2016-11-25 2018-12-28 河南普瑞医药科技有限公司 一种(s)-邻氯苯甘氨酸甲酯盐酸盐的制备方法
CN115784914B (zh) * 2022-12-20 2023-05-12 石家庄中硕科技有限公司 一种邻氯苯甘氨酸的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0355170A4 (en) * 1986-04-24 1990-09-05 N-Proizv Mekh Robot Truda Sover Vertical centrifugal casting machine
FR2624860B1 (fr) * 1987-12-18 1990-06-01 Sanofi Sa Procede de preparation de la n-(chloro-2 benzyl) (thienyl-2)-2 ethylamine
AR245119A1 (es) * 1988-08-22 1993-12-30 Merrell Dow Pharma Procedimiento para preparar un grupo de fenilalquiltiofenos que estan sustituidos adicionalmente con un grupo acido tiadicarboxilico.
FR2664276B1 (fr) * 1990-07-04 1992-10-23 Sanofi Sa Derive thienyl-2 glycidique, son procede de preparation et son utilisation comme intermediaire de synthese.
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.

Also Published As

Publication number Publication date
US6080875A (en) 2000-06-27
DE69814608T2 (de) 2004-04-01
NO994304L (no) 1999-11-03
ES2200332T3 (es) 2004-03-01
JP4283896B2 (ja) 2009-06-24
AU6839498A (en) 1998-09-22
WO1998039322A1 (fr) 1998-09-11
DE69814608D1 (de) 2003-06-18
NO323613B1 (no) 2007-06-18
FR2760456A1 (fr) 1998-09-11
CA2283126A1 (fr) 1998-09-11
BR9808174B1 (pt) 2010-06-29
CA2283126C (fr) 2008-09-02
FR2760456B1 (fr) 2000-05-12
EP0971915A1 (de) 2000-01-19
JP2001513806A (ja) 2001-09-04
EP0971915B1 (de) 2003-05-14
BR9808174A (pt) 2000-05-16
NO994304D0 (no) 1999-09-03

Similar Documents

Publication Publication Date Title
ATE240311T1 (de) Verfahren zur herstellung von 2-thienylamin- derivaten
DE69524251D1 (de) Neue verbindung, verfahren zu ihrer herstellung und antitumormittel
ATE187445T1 (de) Verfahren zur herstellung von chinazolinderivaten
DE50005699D1 (de) Verfahren zur herstellung von thiazolidin
EA200500268A1 (ru) Производные диоксан-2-алкилкарбаматов, способ их получения и применение в терапии
ATE409693T1 (de) Verfahren zur herstellung von 2-(4- chlorbenzoylamino-3- 2(1h)-chinolinon-4-yl propionsäure
DE60311456D1 (de) Verfahren zur herstellung von eisenhydroxypyronverbindungen
ATE343385T1 (de) Verfahren zur herstellung von donepezil
DE69707914D1 (de) Verfahren zur herstellung von einem naphthalenaminderivat
DE69802388D1 (de) Verfahren zur herstellung von nicotinsäuren
ATE250597T1 (de) N-benzolsulfonyl-l-prolin derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DE69604642D1 (de) Verfahren zur herstellung von iodierten kontrastmitteln
DE69818051D1 (de) N-benzenesulfonyl-l-prolin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DE69936350D1 (de) Verfahren zur herstellung fluorierter benzoesäuren
ATE554094T1 (de) Verfahren zur herstellung von 3-cephem- verbindungen
ATE236132T1 (de) Verfahren zur herstellung von 1,3-diaza- spiro(4.4)non-1-en-4-on derivaten und 1-cyano-1- acylaminocyclopentan zwischenprodukte
ATE168982T1 (de) Neues verfahren zur herstellung von beta- alkoxyacrylsäure
ATE330932T1 (de) Verfahren zur herstellung von 3- aminoalkansäureestern
DE69818837D1 (de) Verfahren zur herstellung von 5-hydroxymethylthiazole
DE69015363D1 (de) Verfahren zur herstellung von methylenbisphosphonsäuren.
ATE156824T1 (de) Verfahren zur herstellung von pyrido(1,2- a>pyrimidinderivaten
DE50002236D1 (de) Verfahren zur Herstellung von (Metall)Salzen von Alkylphosphonigen Säuren
ATE226942T1 (de) Verfahren zur herstellung von 1,3-diaza- spiro(4.4)non-1-en-4-on derivaten und 1-cyano-1- acylamino-cyclopentan zwischenprodukten
ATE404540T1 (de) Verfahren zur herstellung von 1-substituierten 5- chlor-4methylpyrazolen
ATE246175T1 (de) Verfahren zur herstellung von a-nor-seco verbindungen mit steran-skelett

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties